TY - JOUR
T1 - Design and recruitment of a large-scale cohort study on prevalence, risk factors and impact evaluation of post-COVID-19 condition and its wider long-term social, mental, and physical health impact
T2 - The PRIME post-COVID study
AU - Pagen, Demi M E
AU - van Bilsen, Céline J A
AU - Brinkhues, Stephanie
AU - Moonen, Chrissy P B
AU - Van Herck, Maarten
AU - Konings, Kevin
AU - den Heijer, Casper D J
AU - Mujakovic, Suhreta
AU - Ter Waarbeek, Henriëtte L G
AU - Bouwmeester-Vincken, Noortje
AU - Vaes, Anouk W
AU - Spruit, Martijn A
AU - Hoebe, Christian J P A
AU - Dukers-Muijrers, Nicole H T M
N1 - Copyright © 2022 Pagen, van Bilsen, Brinkhues, Moonen, Van Herck, Konings, den Heijer, Mujakovic, ter Waarbeek, Bouwmeester-Vincken, Vaes, Spruit, Hoebe and Dukers-Muijrers.
PY - 2022/12/15
Y1 - 2022/12/15
N2 - BACKGROUND: Persistent symptoms, described as long COVID or post-COVID-19 condition, pose a potential public health problem. Here, the design and recruitment of the PRIME post-COVID study is described. PRIME post-COVID is a large-scale population-based observational study that aims to improve understanding of the occurrence, risk factors, social, physical, mental, emotional, and socioeconomic impact of post-COVID-19 condition.METHODS: An observational open cohort study was set up, with retrospective and prospective assessments on various health-conditions and health-factors (medical, demographic, social, and behavioral) based on a public health COVID-19 test and by self-report (using online questionnaires in Dutch language). Invited for participation were, as recorded in a public health registry, adults (18 years and older) who were tested for COVID-19 and had a valid Polymerase Chain Reaction (PCR) positive or negative test result, and email address. In November 2021, 61,655 individuals were invited by email to participate, these included all eligible adults who tested PCR positive between 1 June 2020 and 1 November 2021, and a sample of adults who tested negative (2:1), comparable in distribution of age, sex, municipality of residence and year-quarter of testing. New recruitment periods are planned as well. Participants are followed over time by regular follow-up measurements. Data are analyzed using the appropriate data-analyses methods.DISCUSSION: The PRIME post-COVID study will provide insights into various health-related aspects of post-COVID-19 condition in the context of various stages of the COVID-19 pandemic. Results will inform practical guidance for society, clinical and public health practice for the prevention and care for long-term impact of COVID-19.TRIAL REGISTRATION CLINICALTRIALSGOV IDENTIFIER: NCT05128695.
AB - BACKGROUND: Persistent symptoms, described as long COVID or post-COVID-19 condition, pose a potential public health problem. Here, the design and recruitment of the PRIME post-COVID study is described. PRIME post-COVID is a large-scale population-based observational study that aims to improve understanding of the occurrence, risk factors, social, physical, mental, emotional, and socioeconomic impact of post-COVID-19 condition.METHODS: An observational open cohort study was set up, with retrospective and prospective assessments on various health-conditions and health-factors (medical, demographic, social, and behavioral) based on a public health COVID-19 test and by self-report (using online questionnaires in Dutch language). Invited for participation were, as recorded in a public health registry, adults (18 years and older) who were tested for COVID-19 and had a valid Polymerase Chain Reaction (PCR) positive or negative test result, and email address. In November 2021, 61,655 individuals were invited by email to participate, these included all eligible adults who tested PCR positive between 1 June 2020 and 1 November 2021, and a sample of adults who tested negative (2:1), comparable in distribution of age, sex, municipality of residence and year-quarter of testing. New recruitment periods are planned as well. Participants are followed over time by regular follow-up measurements. Data are analyzed using the appropriate data-analyses methods.DISCUSSION: The PRIME post-COVID study will provide insights into various health-related aspects of post-COVID-19 condition in the context of various stages of the COVID-19 pandemic. Results will inform practical guidance for society, clinical and public health practice for the prevention and care for long-term impact of COVID-19.TRIAL REGISTRATION CLINICALTRIALSGOV IDENTIFIER: NCT05128695.
KW - Adult
KW - Humans
KW - COVID-19/epidemiology
KW - SARS-CoV-2
KW - Cohort Studies
KW - Prospective Studies
KW - Post-Acute COVID-19 Syndrome
KW - Pandemics/prevention & control
KW - Retrospective Studies
KW - Prevalence
KW - Risk Factors
U2 - 10.3389/fpubh.2022.1032955
DO - 10.3389/fpubh.2022.1032955
M3 - Article
C2 - 36589958
SN - 2296-2565
VL - 10
SP - 1032955
JO - Frontiers in Public Health
JF - Frontiers in Public Health
M1 - 1032955
ER -